COMMENTARIES
Open Access
Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
Lisa Stevens, Kelly E. Perry, Iakuna Moide, Francil Kaemala, Justine Nankinga, Anh L. Innes and Ignatius Mogaba
Global Health: Science and Practice April 2022, 10(2):e2100595; https://doi.org/10.9745/GHSP-D-21-00595
Lisa Stevens
aFHI 360 Asia Pacific Regional Office, Bangkok, Thailand.
Kelly E. Perry
aFHI 360 Asia Pacific Regional Office, Bangkok, Thailand.
Iakuna Moide
bFHI 360 Papua New Guinea Office, Port Moresby, Papua New Guinea.
Francil Kaemala
bFHI 360 Papua New Guinea Office, Port Moresby, Papua New Guinea.
Justine Nankinga
bFHI 360 Papua New Guinea Office, Port Moresby, Papua New Guinea.
Anh L. Innes
cFHI 360 Vietnam Office, Hanoi, Vietnam.
Ignatius Mogaba
bFHI 360 Papua New Guinea Office, Port Moresby, Papua New Guinea.
Supplemental material
- Supplement -
Supplement
- Supplement -
In this issue
Global Health: Science and Practice
Vol. 10, No. 2
April 28, 2022
Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
Lisa Stevens, Kelly E. Perry, Iakuna Moide, Francil Kaemala, Justine Nankinga, Anh L. Innes, Ignatius Mogaba
Global Health: Science and Practice Apr 2022, 10 (2) e2100595; DOI: 10.9745/GHSP-D-21-00595
Leveraging Experience From Active TB Drug-Safety Monitoring and Management for Monitoring Active Antiretroviral Toxicity
Lisa Stevens, Kelly E. Perry, Iakuna Moide, Francil Kaemala, Justine Nankinga, Anh L. Innes, Ignatius Mogaba
Global Health: Science and Practice Apr 2022, 10 (2) e2100595; DOI: 10.9745/GHSP-D-21-00595
Statistics from Altmetric.com
Jump to section
Related Articles
Cited By...
- No citing articles found.